newsfilter
← Latest News
GlobeNewswire·

Collegium to Report Third Quarter 2026 Financial Results on November 5, 2026

STOUGHTON, Mass., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (NASDAQ:COLL), a leading biopharmaceutical company focused on improving the lives of people living with serious and often